Abstract
Language proficiency is an integral aspect of patient-provider communication, and it affects healthcare choices and access. Disparities in access to biologic medications in psoriasis patients exist, but the influence of English proficiency is unknown. We conducted a cross-sectional study using the Medical Expenditure Panel Survey (MEPS) from 2013 to 2017 to compare biologic medication use among psoriasis patients of differing English proficiency. We compared patients in exclusively English speaking households to patients with a family member who speaks a language other than English at home, which we defined as having as less than perfect English proficiency.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.